查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869734

美國周邊神經刺激設備市場規模、佔有率和趨勢分析報告：按產品類型、模式、性別、應用、最終用途和細分市場預測（2025-2033 年）

U.S. Peripheral Nerve Stimulators Market Size, Share & Trends Analysis Report By Product Type (Systems, Wearables/Accessories), By Modality (Rechargeable, Non-rechargeable), By Connectivity, By Application, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

據估計，2024年美國周邊神經刺激設備市值為1.0514億美元，預計2033年將達到2.5336億美元。

預計從 2025 年到 2033 年，該產業將以 10.43% 的複合年成長率成長。美國周邊神經刺激設備產業的主要驅動力是慢性疼痛疾病的日益普遍、對微創和標靶疼痛管理療法的需求不斷成長，以及向非鴉片類藥物療法的轉變。

醫療專業人員和患者對周邊神經刺激改善生活品質的有效性認知不斷提高，推動了該技術的普及應用。植入式系統、穿戴式刺激器和先進的可編程性等技術進步進一步促進了市場成長。門診手術中心的擴張、有利的報銷政策以及人口老化帶來的高手術量，都為市場的持續成長做出了貢獻。

慢性疾病的日益普遍推動了美國周邊神經刺激設備產業的成長，因為患有糖尿病、肥胖症、高血壓、氣喘和慢性疼痛等疾病的患者越來越需要有針對性的長期疼痛管理方案。周邊神經刺激設備提供了一種微創治療選擇，可以緩解這些疾病引起的疼痛，從而改善患者的治療效果和生活品質。

例如，正如健康系統追蹤機構（Health System Tracker）在2025年4月指出的那樣，美國的慢性病患病率高於其他國家，其中肥胖症和糖尿病的患病率是其他國家的兩倍多，氣喘率是其他國家的1.7倍，憂鬱症的總體負擔也更重。這些高盛行率不僅增加了對先進疼痛管理療法的需求，也顯示了對有效且經臨床驗證的周邊神經刺激解決方案的迫切需求。根據泛美衛生組織（PAHO）2025年7月的報告，心血管疾病是導致死亡的主要原因（216萬人死亡），其次是癌症（137萬人死亡）、糖尿病（超過42萬人死亡）和慢性呼吸系統疾病（超過41.6萬人死亡）。自殺是15至29歲年輕人死亡的第四大原因，奪走了100,760人的生命。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章美國周邊神經刺激設備市場變數、趨勢與範圍

  • 市場體系展望
    • 補貼市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 美國周邊神經刺激設備市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析

第4章美國周邊神經刺激設備市場：產品類型估算與趨勢分析

  • 細分儀表板
  • 美國周邊神經刺激設備市場產品類型差異分析
  • 美國周邊神經刺激設備市場規模及趨勢分析（按產品類型分類）（2021-2033 年）
  • 系統
  • 穿戴式裝置/配件

第5章美國周邊神經刺激設備市場：模式估算與趨勢分析

  • 細分儀表板
  • 美國周邊神經刺激設備市場趨勢與波動分析
  • 美國周邊神經刺激設備市場規模及趨勢分析（按模式分類，2021-2033 年）
  • 可充電的
  • 不可充電

第6章美國周邊神經刺激設備市場：連結性估算與趨勢分析

  • 細分儀表板
  • 美國周邊神經刺激設備市場連結性波動分析
  • 美國周邊神經刺激設備市場規模及趨勢分析（依接取方式分類，2021-2033 年）
  • 有線
  • 無線的

第7章美國周邊神經刺激設備市場：應用預測與趨勢分析

  • 細分儀表板
  • 美國周邊神經刺激設備市場應用趨勢分析
  • 美國周邊神經刺激設備市場規模及趨勢分析（依接取方式分類，2021-2033 年）
  • 糖尿病周邊神經病變疼痛
  • 慢性肌肉骨骼疼痛
  • 複雜性局部疼痛症候群（CRPS）
  • 頭痛和偏頭痛
  • 其他

第8章美國周邊神經刺激設備市場：終端用途預測與趨勢分析

  • 細分儀表板
  • 美國周邊神經刺激設備市場最終用途變化分析
  • 美國周邊神經刺激設備市場規模及趨勢分析（按最終用途分類）（2021-2033 年）
  • 醫院和診所
  • 門診手術中心（ASC）
  • 物理治療/復健中心
  • 其他

第9章 競爭情勢

  • 市場參與企業分類
  • 主要企業簡介
    • B. Braun Medical Inc.
    • Nalu Medical, Inc
    • Curonix LLC.
    • SPR
    • Vygon
    • AirLife
    • Neuspera Medical
    • Anesthesia Associates, Inc.
    • AVNS
    • Mercury Medical
    • Medtronic
    • Boston Scientific Corporation
    • Abbott
    • Bioventus
    • Checkpoint Surgical Inc.
    • Nervonik, Inc
  • 公司市佔率分析，2024 年
  • 其他主要市場參與者名單
Product Code: GVR-4-68040-771-2

Market Size & Trends:

The U.S. peripheral nerve stimulators market size was estimated at USD 105.14 million in 2024 and is projected to reach USD 253.36 million by 2033, growing at a CAGR of 10.43% from 2025 to 2033. The U.S. peripheral nerve stimulators industry is primarily driven by the rising prevalence of chronic pain conditions and increasing demand for minimally invasive, targeted pain management therapies, and the growing shift toward non-opioid therapies.

Growing awareness among healthcare providers and patients about the effectiveness of peripheral nerve stimulation in improving quality of life is fueling adoption. Technological advancements, including implantable systems, wearable stimulators, and enhanced programmable features, further propel market growth. The expansion of outpatient and ambulatory surgery centers, favorable reimbursement policies, and an aging population with higher surgical volumes contribute to the sustained momentum of the market.

Rising prevalence of chronic diseases continues to drive growth in the U.S. peripheral nerve stimulators industry, as patients with conditions such as diabetes, obesity, hypertension, asthma, and chronic pain increasingly require targeted, long-term pain management solutions. Peripheral nerve stimulators offer minimally invasive options to alleviate pain associated with these illnesses, improving patient outcomes and quality of life.

For instance, in April 2025, Health System Tracker highlighted that the U.S. has a higher rate of chronic diseases compared to peer nations, with over twice as many people affected by obesity and diabetes, 1.7 times more with asthma, and an overall higher burden of depression. This elevated prevalence of chronic conditions not only increases demand for advanced pain management therapies but also underscores the growing need for effective, clinically proven peripheral nerve stimulation solutions. According to the Pan American Health Organization's (PAHO) report, in July 2025, cardiovascular diseases led with 2.16 million deaths, followed by cancer (1.37 million), diabetes (over 420,000), and chronic respiratory conditions (more than 416,000). Suicide, the fourth leading cause of death among youth aged 15-29, claimed 100,760 lives.

U.S. Peripheral Nerve Stimulators Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. peripheral nerve stimulators market report based on product type, modality, connectivity, application, and end use:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Systems
  • Implantable
  • Non-implantable
    • Handheld
    • Others
  • Wearables/Accessories
  • Modality Outlook (Revenue, USD Million, 2021 - 2033)
  • Rechargeable
  • Non-rechargeable
  • Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
  • Wired
  • Wireless
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Diabetic Peripheral Neuropathy Pain
  • Chronic Musculoskeletal Pain
  • Complex Regional Pain Syndrome (CRPS)
  • Headache and Migraine Disorders
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Physiotherapy/Rehabilitation Centers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Modality
    • 1.2.3. Connectivity
    • 1.2.4. Application
    • 1.2.5. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
    • 1.5.5. Information Analysis
    • 1.5.6. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Peripheral Nerve Stimulators Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High and rising prevalence of chronic pain
      • 3.2.1.2. Shift away from opioids toward non-opioid/interventional therapies
      • 3.2.1.3. Evidence and real-world adoption showing clinical benefit
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High device and procedure costs
      • 3.2.2.2. Technological limitations
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Outpatient centers and ambulatory surgery as key settings
      • 3.2.3.2. Aging population and comorbidities
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Device-related risks and complications
      • 3.2.4.2. Intense market competition
  • 3.3. U.S. Peripheral Nerve Stimulators Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Peripheral Nerve Stimulators Market: Product Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Peripheral Nerve Stimulators Market Product Type Movement Analysis
  • 4.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
  • 4.4. Systems
    • 4.4.1. Systems U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.1. Implantable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.4.1.1.1. Handheld
        • 4.4.1.1.2. Others
      • 4.4.1.2. Non-implantable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Wearables/Accessories
    • 4.5.1. Wearables/Accessories U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Peripheral Nerve Stimulators Market: Modality Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Peripheral Nerve Stimulators Market Modality Movement Analysis
  • 5.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Modality, 2021 to 2033 (USD Million)
  • 5.4. Rechargeable
    • 5.4.1. Rechargeable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Non-rechargeable
    • 5.5.1. Non-rechargeable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Peripheral Nerve Stimulators Market: Connectivity Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Peripheral Nerve Stimulators Market Connectivity Movement Analysis
  • 6.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
  • 6.4. Wired
    • 6.4.1. Wired U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Wireless
    • 6.5.1. Wireless U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Peripheral Nerve Stimulators Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Peripheral Nerve Stimulators Market Connectivity Movement Analysis
  • 7.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
  • 7.4. Diabetic Peripheral Neuropathy Pain
    • 7.4.1. Diabetic Peripheral Neuropathy Pain U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Chronic Musculoskeletal Pain
    • 7.5.1. Chronic Musculoskeletal Pain U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Complex Regional Pain Syndrome (CRPS)
    • 7.6.1. Complex Regional Pain Syndrome (CRPS) U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Headache and Migraine Disorders
    • 7.7.1. Headache and Migraine Disorders U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Others U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Peripheral Nerve Stimulators Market: End-Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Peripheral Nerve Stimulators Market End-Use Movement Analysis
  • 8.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by End-Use, 2021 to 2033 (USD Million)
  • 8.4. Hospitals and Clinics
    • 8.4.1. Hospitals and Clinics U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Ambulatory Surgical Centers (ASCs)
    • 8.5.1. Ambulatory Surgical Centers (ASCs) U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Physiotherapy/Rehabilitation Centers
    • 8.6.1. Physiotherapy/Rehabilitation Centers U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Others
    • 8.7.1. Others U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. B. Braun Medical Inc.
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Modality Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Nalu Medical, Inc
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Modality Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Curonix LLC.
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Modality Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. SPR
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Modality Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Vygon
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Modality Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. AirLife
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Modality Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Neuspera Medical
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Modality Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Anesthesia Associates, Inc.
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Modality Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. AVNS
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Modality Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Mercury Medical
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Modality Benchmarking
      • 9.2.10.4. Strategic Initiatives
    • 9.2.11. Medtronic
      • 9.2.11.1. Company Overview
      • 9.2.11.2. Financial Performance
      • 9.2.11.3. Modality Benchmarking
      • 9.2.11.4. Strategic Initiatives
    • 9.2.12. Boston Scientific Corporation
      • 9.2.12.1. Company Overview
      • 9.2.12.2. Financial Performance
      • 9.2.12.3. Modality Benchmarking
      • 9.2.12.4. Strategic Initiatives
    • 9.2.13. Abbott
      • 9.2.13.1. Company Overview
      • 9.2.13.2. Financial Performance
      • 9.2.13.3. Modality Benchmarking
      • 9.2.13.4. Strategic Initiatives
    • 9.2.14. Bioventus
      • 9.2.14.1. Company Overview
      • 9.2.14.2. Financial Performance
      • 9.2.14.3. Modality Benchmarking
      • 9.2.14.4. Strategic Initiatives
    • 9.2.15. Checkpoint Surgical Inc.
      • 9.2.15.1. Company Overview
      • 9.2.15.2. Financial Performance
      • 9.2.15.3. Modality Benchmarking
      • 9.2.15.4. Strategic Initiatives
    • 9.2.16. Nervonik, Inc
      • 9.2.16.1. Company Overview
      • 9.2.16.2. Financial Performance
      • 9.2.16.3. Modality Benchmarking
      • 9.2.16.4. Strategic Initiatives
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. List of Other Key Market Players

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Peripheral Nerve Stimulators Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 4 U.S. Peripheral Nerve Stimulators Market, by Modality, 2021 - 2033 (USD Million)
  • Table 5 U.S. Peripheral Nerve Stimulators Market, by Connectivity, 2021 - 2033 (USD Million)
  • Table 6 U.S. Peripheral Nerve Stimulators Market, by Application, 2021 - 2033 (USD Million)
  • Table 7 U.S. Peripheral Nerve Stimulators Market, by End-Use, 2021 - 2033 (USD Million)
  • Table 8 Participant's Overview
  • Table 9 Financial Performance
  • Table 10 Modality Benchmarking
  • Table 11 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Peripheral Nerve Stimulators Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Regional Marketplace: Key Takeaways
  • Fig. 13 U.S. Peripheral Nerve Stimulators Market, for Product Type, 2021 - 2033 (USD Million)
  • Fig. 14 U.S. Peripheral Nerve Stimulators Market, for Systems, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Peripheral Nerve Stimulators Market, for Implantable, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Peripheral Nerve Stimulators Market, for Non-Implantable, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Peripheral Nerve Stimulators Market, for Handheld, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Peripheral Nerve Stimulators Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Peripheral Nerve Stimulators Market, for Wearables/Accessories, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Peripheral Nerve Stimulators Market, for Rechargeable, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Peripheral Nerve Stimulators Market, for Non-rechargeable, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Peripheral Nerve Stimulators Market, for Connectivity, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Peripheral Nerve Stimulators Market, for Wired, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Peripheral Nerve Stimulators Market, for Wireless, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Peripheral Nerve Stimulators Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Peripheral Nerve Stimulators Market, for Diabetic Peripheral Neuropathy Pain, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Peripheral Nerve Stimulators Market, for Chronic Musculoskeletal Pain, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Peripheral Nerve Stimulators Market, for Complex Regional Pain Syndrome (CRPS), 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Peripheral Nerve Stimulators Market, for Headache and Migraine Disorders, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. Peripheral Nerve Stimulators Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Peripheral Nerve Stimulators Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Peripheral Nerve Stimulators Market, for Hospitals and Clinics, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Peripheral Nerve Stimulators Market, for Ambulatory Surgical Centers (ASCs), 2021 - 2033 (USD Million)
  • Fig. 34 U.S. Peripheral Nerve Stimulators Market, for Physiotherapy/Rehabilitation Centers, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. Peripheral Nerve Stimulators Market, for Others, 2021 - 2033 (USD Million)